Abstract: A method for cleaning, sanitizing, and disinfecting commercial and residential HVAC system includes applying low pressure cleaning foam to heat-exchange coils of the HVAC system, the cleaning foam including one or more agents that break down organic and/or inorganic fouling dirt or debris, the foam removing and carrying away dirt or debris from the coils. Moving air, such as from the air handler of the HVAC system, pushes or draws the cleaning foam from the first side of the coils toward a second side, the cleaning foam and removed dirt or debris exiting the second side of the coils. The moving air and cleaning foam move co-currently in the same direction through spaces in the coils.

Abstract: The present invention relates to a drug delivery system and uses thereof. Specifically, a system that can be used to deliver therapeutic proteins, including antibodies, to proteolytic environments is disclosed. In one form of the invention the drug delivery system is a composition which comprises a porous substrate and an antibody bound to the substrate. In one embodiment, the composition comprises nanoporous silicon and can be used to deliver antibodies for the treatment, or for improving the repair, of a wound.

Abstract: Drug delivery devices and systems are disclosed that allow precise, controlled drug delivery via the oral palatal mucosa. The drug delivery devices can be easily used by a patient or other user, and reduce the likelihood of (or in some cases eliminate) dilution of the drug by saliva and fluids and inadvertent swallowing or unplanned uptake of the drug by the patient. The drug delivery devices include a body shaped to conform to a user's palate, and cavities in a palate-facing surface of the body that are configured to receive a drug in liquid form.

Abstract: A tracking apparatus for a machine having an operation assembly is disclosed. The tracking apparatus has an electric relay configured to be connected to the operation assembly, a tracking device that is connected to the electric relay, and a display assembly that is selectively connected to the electric relay. The display assembly is configured to transfer an electrical pulse from the display assembly to the tracking device via the electric relay. The operation assembly performs an operation when the electrical pulse is transferred to the tracking device. The tracking device counts the electrical pulse.

Abstract: A tracking apparatus for a machine having an operation assembly is disclosed. The tracking apparatus has an electric relay configured to be connected to the operation assembly, a tracking device that is connected to the electric relay, and an electronic payment device that is connected to the electric relay. The electric relay is configured to transfer a first electrical pulse from the operation assembly to the tracking device. The electric relay is configured to transfer a second electrical pulse from either the electronic payment device or the operation assembly to the tracking device. The relay transfers the first electrical pulse or the second electrical pulse when the operation assembly performs an operation.

Abstract: An analysis instrument comprises plural modules connected together over a data network, each module comprising an analysis apparatus operable to perform biochemical analysis of a sample. Each module comprises a control unit that controls the operation of the analysis apparatus. The control units are addressable to select an arbitrary number of modules to operate as a cluster for performing a common biochemical analysis. The control units communicate over the data network, repeatedly during the performance of the common biochemical analysis, to determine the operation of the analysis apparatus of each module required to meet the global performance targets, on the basis of measures of performance derived from the output data produced by the modules. The arrangement of the instrument as modules interacting in this manner provides a scalable analysis instrument.

Abstract: According to aspects of the invention there is provided a remote unit comprising a processor and one or more terminal interfaces, the processor being connected to the one or more terminal interfaces, the terminal interfaces configured for coupling with a set of terminals, wherein the processor is configured to perform quality of service network testing using one or more of the set of terminals over one or more communication networks.

Abstract: This disclosure pertains generally to the field of chemical synthesis and purification, and more specifically to methods of synthesizing and purifying certain 3,7 diamino-phenothiazin-5-ium compounds (referred to herein as “diaminophenothiaziniumcompounds”) including Methythioninium Chloride (MTC) (also known as Methylene Blue). In one embodiment, the method comprises the steps of, in order: nitrosylation (NOS); nitrosyl reduction (NR); thiosulfonic acid formation (TSAF); oxidative coupling (OC); Cr(VI) reduction (CR); isolation and purification of zwitterionic intermediate (IAPOZI); ring closure (RC); chloride salt-formation (CSF); one of: sulphide treatment (ST); dimethyldithiocarbamate treatment (DT); carbonate treatment (CT); ethylenediaminetetraacetic acid treatment (EDTAT); organic extraction (OE); and recrystallisation (RX). Also disclosed resulting (high purity) compounds, compositions comprising them (e.g.

Abstract: The present disclosure relates to a sensor comprising: an array of photodetectors comprising a first subarray of at least one photodetector and a second subarray of at least one photodetector; a first optical arrangement to direct incoming photons toward the first subarray; and a second optical arrangement to direct incoming photons toward the second subarray.

Abstract: Disclosed are methods of synthesis and/or purification of certain 3,7-diamino-phenothiazin-5-ium compounds (“diaminophenothiazinium compounds”) including Methylthioninium Chloride (MTC) (Methylene Blue), and the resulting high purity characterized by a purity greater than 98%, and very low levels of heavy metals and organic impurities Azure A, B, C and MVB. Also disclosed are methods of treatment of a tauopathy or methemoglobinemia in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of the high-purity diaminophenothiazinium compound.

Abstract: A multi-channel control system includes at least a primary control microprocessor and a back-up control microprocessor operable to control a device. The primary control microprocessor and the back-up control microprocessor assert control over a controlled device according to a locally stored method of controlling a back-up microprocessor assumption of control of a device.

Abstract: Embodiments are directed to a construction plan management system. Embodiments retrieve a drawing corresponding to the construction plan, the drawing including document coordinates. Embodiments render the drawing. Embodiments retrieve a data object corresponding to an issue that corresponds to the construction plan, the data object including pinstore coordinates. Embodiments generate a viewport layer on top of the rendered drawing, the viewport layer including viewport coordinates. Embodiments convert the pinstore coordinates of the data object to converted viewport coordinates and display the data object as a pin on the viewport layer using the converted viewport coordinates.

Abstract: Disclosed are compounds of general formula (I): and pharmaceutically acceptable salts thereof, formulations, methods and uses in, for example, the treatment of disease.

Abstract: A method of forming a dietary supplement can include steps of creating a composition of matter comprising CDP and GPC; and providing the composition of matter in a liquid or solid form. Providing the composition of matter can include filling a container with the composition of matter.

Abstract: A method of forming a dietary supplement can include steps of creating a composition of matter comprising sakae naa and CDP; and providing the composition of matter in a liquid or solid form. Providing the composition of matter can include filling a container with the composition of matter.

Abstract: A method of forming a dietary supplement can include steps of creating a composition of matter comprising kava and CDP; and providing the composition of matter in a liquid or solid form. Providing the composition of matter can include filling a container with the composition of matter.

Abstract: A method of forming a dietary supplement can include steps of creating a composition of matter comprising kava and GPC; and providing the composition of matter in a liquid or solid form. Providing the composition of matter can include filling a container with the composition of matter.

Abstract: A method of forming a dietary supplement can include steps of creating a composition of matter comprising sakae naa and GPC; and providing the composition of matter in a liquid or solid form. Providing the composition of matter can include filling a container with the composition of matter.

Abstract: A method of forming a dietary supplement can include steps of creating a composition of matter comprising tianeptine and GPC; and providing the composition of matter in a liquid or solid form. The ingredient of tianeptine can be tianeptine sodium, tianeptine free acid, or both. Providing the composition of matter can include filling a container with the composition of matter.

Abstract: A method of forming a dietary supplement can include steps of creating a composition of matter comprising sakae naa and kava; and providing the composition of matter in a liquid or solid form. Providing the composition of matter can include filling a container with the composition of matter.